News
PBH
70.68
+0.40%
0.28
Weekly Report: what happened at PBH last week (0715-0719)?
Weekly Report · 4d ago
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly
Prestige Consumer Healthcare Inc. Has US$1.13b of debt. The balance sheet is a good indicator of a company's ability to manage its debt. It has a debt to EBITDA ratio of 2.9 and its EBIT covered its interest expense 5.1 times. The company does carry debt, but is it risky? We look at the company's debt to see if the debt is making the company risky. Prestige consumer healthcare's debt levels are lower than its future earnings.
Simply Wall St · 07/16 12:58
Weekly Report: what happened at PBH last week (0708-0712)?
Weekly Report · 07/15 09:08
AHCO or PBH: Which Is the Better Value Stock Right Now?
NASDAQ · 07/09 15:40
Weekly Report: what happened at PBH last week (0701-0705)?
Weekly Report · 07/08 09:08
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
Prestige Consumer Healthcare Inc. Will issue its fiscal 2025 first quarter earnings release on Thursday, August 8, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
Barchart · 07/02 15:30
Weekly Report: what happened at PBH last week (0624-0628)?
Weekly Report · 07/01 09:09
Weekly Report: what happened at PBH last week (0617-0621)?
Weekly Report · 06/24 09:09
DA Davidson Upgrades Prestige Consumer Healthcare (PBH)
NASDAQ · 06/22 05:07
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Oppenheimer analyst Brian Nagel upgraded the rating for NIKE, Inc. From Perform to Outperform. Morgan Stanley upgraded Alcoa Corporation from Equal-Weight to Overweight and boosted the price target from $36.5 to $50. The company's shares gained 0.8% on Thursday.
Benzinga · 06/21 16:28
Prestige Consumer Hlthcr Raised to Buy From Neutral by DA Davidson
Dow Jones · 06/21 13:43
Prestige Consumer Hlthcr Price Target Raised to $93.00/Share From $65.00 by DA Davidson
Dow Jones · 06/21 13:43
DA Davidson Upgrades Prestige Consumer to Buy, Raises Price Target to $93
Benzinga · 06/21 13:34
Is Weakness In Prestige Consumer Healthcare Inc. (NYSE:PBH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Prestige Consumer Healthcare (NYSE:PBH) has a 13% return on equity of 13%. The company's net income growth over the last five years has been low. Its ROE of 13% shows the company is reinvesting its profits into the business. The company has a high rate of return, but its earnings growth has been slower than the industry average. Prestige consumer Healthcare is down 11% from its peak in 2007. It has a good ROE, but the company has low earnings growth.
Simply Wall St · 06/19 11:23
Weekly Report: what happened at PBH last week (0610-0614)?
Weekly Report · 06/17 09:08
Prestige Consumer Healthcare (PBH) Down 0.4% Since Last Earnings Report: Can It Rebound?
NASDAQ · 06/13 15:30
Tracking John Rogers' Ariel Investments Portfolio - Q1 2024 Update
Seeking Alpha · 06/11 23:39
Weekly Report: what happened at PBH last week (0603-0607)?
Weekly Report · 06/10 09:09
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
Prestige Consumer Healthcare Inc. Will present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference on June 10, 2024. All interested parties may access a live webcast of the event at www.prestigeconsumerhealthcare.com.
Barchart · 06/06 15:30
Weekly Report: what happened at PBH last week (0527-0531)?
Weekly Report · 06/03 09:09
More
Webull provides a variety of real-time PBH stock news. You can receive the latest news about Prestige Consmr Healthcare Inc through multiple platforms. This information may help you make smarter investment decisions.
About PBH
Prestige Consumer Healthcare Inc. is consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. It operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.